https://www.bioworld.com/
BioWorld: The Daily Biopharmaceutical and Medical Technology News Source
Daily news and analysis of the global biotechnology, pharmaceutical and medical technology industries.
the dailymedical technologybioworldbiopharmaceuticalnews
https://www.bioworld.com/articles/705155-seegene-pushes-ambitious-dtx-tech-sharing-initiative-with-microsoft?v=preview
Seegene pushes ambitious DTx tech-sharing initiative with Microsoft | BioWorld
In a post-pandemic world, South Korean molecular diagnostics firm Seegene Inc. is looking to ignite a new paradigm in the diagnostics business. Seoul-based...
tech sharingwith microsoftpushesambitiousdtx
https://www.bioworld.com/articles/topic/85-bioworld-medtech?page=68
Medical technology - Articles - Page 68 | BioWorld
Daily news and analysis of the medical technology industry. In-depth coverage of business, financing, regulation, science, innovation, device approvals,...
medical technologyarticles pagebioworld
https://www.bioworld.com/articles/643950-phase-i-study-begins-for-mva-bn-filo-advac-preventive-ebola-vaccine-regimen?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/724107-appointments-and-advancements-for-sept-17-2025?v=preview
Appointments and advancements for Sept. 17, 2025 | BioWorld
New hires and promotions in the med-tech industry, including: Cirtec Medical, InspireMD, Kestra Medical.
appointmentsadvancementsseptbioworld
https://www.bioworld.com/articles/722776-nanjing-gentai-pharmaceutical-technology-identifies-new-parp-1-ulk1-dual-inhibitors?v=preview
Nanjing Gentai Pharmaceutical Technology identifies new PARP-1/ULK1 dual inhibitors | BioWorld
Nanjing Gentai Pharmaceutical Technology Co. Ltd. has divulged dual inhibitors of poly(ADP-ribose) polymerase 1 (PARP-1; ARTD1) and serine/threonine-protein...
pharmaceutical technology
https://www.bioworld.com/articles/698786-in-the-clinic-for-july-11-17-2023?v=preview
In the clinic for July 11-17, 2023 | BioWorld
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Hangzhou, Hutchmed, Reece, Sciwind.
in the clinicjulybioworld
https://www.bioworld.com/articles/649072-trpv1-and-trpa1-activation-reduces-muscular-cramps?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/670264-fda-approves-esperoct-for-hemophilia-a?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/714568-telix-signs-purchase-license-agreements-for-fap-targeting-compounds?v=preview
Telix signs purchase, license agreements for FAP-targeting compounds | BioWorld
Telix Pharmaceuticals Ltd. is expanding its theranostic pipeline with new assets targeting fibroblast activation protein (FAP). The company has entered into...
purchase licensesignsagreementsfaptargeting
https://www.bioworld.com/articles/431921-fda-grants-accelerated-approval-for-padcev-to-treat-urothelial-cancer?v=preview
FDA grants accelerated approval for Padcev to treat urothelial cancer | 2019-12-19 | BioWorld
A mere 26 months after the first patient was enrolled in its pivotal phase II study and about three months ahead of its PDUFA date, the FDA granted accelerated...
https://www.bioworld.com/articles/730910-new-smarca2-degrader-for-smarca4-deficient-cancers-described?v=preview
New SMARCA2 degrader for SMARCA4-deficient cancers described | BioWorld
SMARCA4-deficient cells have shown dependency on SMARCA2 for survival, suggesting SMARCA2 as a promising synthetic lethal target in SMARCA4-deficient cancers....
newdegradercancersdescribedbioworld
https://www.bioworld.com/articles/659303-novel-drosophila-fxs-model-as-promising-screening-strategy-for-therapeutic-discovery?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/667268-university-of-michigan-describes-bromodomain-and-extra-terminal-protein-inhibitors?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/670141-gyeonggido-business-science-accelerator-korpharm-disclose-benzylidene-acetone-derivatives?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/714510-fda-unveils-pilot-program-for-improved-device-recall-transparency?v=preview
FDA unveils pilot program for improved device recall transparency | BioWorld
The FDA announced a new pilot program for communication of medical device recalls, but industry may be wary of a program that seems to be driven toward early...
pilot programfdaunveilsimproveddevice
https://www.bioworld.com/articles/661803-fda-grants-priority-review-to-imfinzi-sbla-for-locally-advanced-unresectable-nsclc?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/648287-topline-phase-ii-data-on-gkt-137831-support-development-in-fibrotic-diseases?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/659639-genmab-reports-data-from-cervical-cancer-cohort-of-phase-i-ii-study-of-tisotumab-vedotin?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/704748-following-jpm-2024-outlook-ranges-from-hopeful-to-cautious
Following JPM, 2024 outlook ranges from hopeful to cautious | BioWorld
A preview of the next edition of BioWorld, Jan. 19, 2024
followingjpmoutlookrangeshopeful
https://www.bioworld.com/articles/705250-other-news-to-note-for-feb-13-2024?v=preview
Other news to note for Feb. 13, 2024 | BioWorld
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biofourmis, Cyclomics, Deepc, Gedi Cube, Implantica,...
news to notefebbioworld
https://www.bioworld.com/articles/659446-teva-reports-results-from-second-phase-iii-halo-study-of-fremanezumab?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/730652-icymi-week-in-review-april-20-24-2026?v=preview
ICYMI: Week in review, April 20-24, 2026 | BioWorld
A quick look back at top stories.
week in reviewicymiaprilbioworld
https://www.bioworld.com/articles/681870-suzhou-kintor-pharmaceuticals-patents-c-myc-inhibitors?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/643331-fda-approves-onexton-gel-for-the-treatment-of-acne-vulgaris?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/708095-novorex-discloses-yeats-domain-inhibitors-for-cancer?v=preview
Novorex discloses yeats domain inhibitors for cancer | BioWorld
Novorex Inc. has patented protein ENL (MLLT1; YEATS1) and protein AF-9 (MLLT3; AF9) inhibitors reported to be useful for the treatment of cancer.
for canceryeatsdomaininhibitorsbioworld
https://www.bioworld.com/articles/711502-mid1-involved-in-liver-injury-by-promoting-immune-infiltration?v=preview
MID1 involved in liver injury by promoting immune infiltration | BioWorld
Hepatic ischemia-reperfusion injury (HIRI) is a common leading cause of liver injury and is associated with several clinical conditions, including liver...
involvedliverinjurypromotingimmune
https://www.bioworld.com/articles/728811-dewpoint-nominates-myc-condensate-modulator-candidate?v=preview
Dewpoint nominates MYC condensate modulator candidate | BioWorld
Dewpoint Therapeutics Inc. has selected a development candidate in its MYC program. The first-in-class small molecule is designed to disrupt MYC-driven...
dewpointmyccondensatemodulatorcandidate
https://www.bioworld.com/articles/675068-roche-publishes-data-from-imatrix-study-of-atezolizumab?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/697642-med-tech-gainers-and-losers-for-may-29-june-2-2023?v=preview
Med-tech gainers and losers for May 29-June 2, 2023 | BioWorld
The top 10 med-tech stock gainers and losers for the week.
gainers and losersmed tech
https://www.bioworld.com/articles/670896-revcovi-approved-in-japan-for-ada-deficiency?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/682600-dosing-begins-in-first-in-human-study-of-can-106-for-complement-dysregulation-diseases?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/691434-clovis-faces-bankruptcy-as-rubraca-revenues-fall-amid-regulatory-crackdown-on-parp-class
Clovis faces bankruptcy as Rubraca revenues fall amid regulatory crackdown on PARP class | BioWorld
A preview of the next edition of BioWorld, Nov. 9, 2022
https://www.bioworld.com/articles/661623-ligand-pharmaceuticals-to-acquire-crystal-bioscience?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/724550-fda-continues-to-build-regenerative-medicine-pathway?v=preview
FDA continues to build regenerative medicine pathway | BioWorld
The U.S. FDA released a trio of draft guidances to help sponsors in developing and monitoring cell and gene therapies, as well as other regenerative medicine...
to buildregenerative medicinefdacontinuespathway
https://www.bioworld.com/articles/698798-ovx-033-vaccine-exhibits-broad-protection-against-sars-cov-2-in-preclinical-models?v=preview
OVX-033 vaccine exhibits broad protection against SARS-CoV-2 in preclinical models | BioWorld
The protection against SARS-CoV-2 provided by spike-based vaccines, although effective, tends to decrease as the virus evolves and new variants of concern...
https://www.bioworld.com/articles/topic/520,154-conferences-bioworld-science?page=3074
BioWorld Science - Articles - Page 3074
Daily news focused on drug discovery, delivery and preclinical research. Coverage includes: Congress highlights, key studies from peer-reviewed journals,...
bioworld sciencearticles page
https://www.bioworld.com/articles/655913-chmp-supports-approval-of-abbvie-s-humira-for-adolescents-with-hidradenitis-suppurativa?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.jedishop.eu/star-wars-messenger-bag-a-new-hope-messenger-901907846/
Star Wars Messenger Bag A New Hope Messenger Bioworld EU
- High quality Messenger Bag - Officially licensed - Material: 100% Polyester - Size: 38 x 30 x 10 cm
a new hopestar warsmessenger bagbioworldeu
https://www.bioworld.com/articles/694438-ripk2-drives-prostate-cancer-progression-and-is-a-useful-prognostic-marker?v=preview
RIPK2 drives prostate cancer progression and is a useful prognostic marker | BioWorld
Receptor-interacting serine/threonine-protein kinase 2 (RIPK2) is a kinase protein that plays key roles in inflammation and antimicrobial response through the...
prostate cancer
https://www.bioworld.com/articles/643246-transition-therapeutics-reports-results-from-elnd-005-study?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/648213-patupilone-active-against-brain-metastases-from-non-small-cell-lung-cancer?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/730476-financings-for-april-20-2026?v=preview
Financings for April 20, 2026 | BioWorld
Biopharma and med-tech companies raising money in public or private financings, including: Allogene, Alloy, Enveric, JATT II, Orthogon, Spyre, Trevi,...
financingsaprilbioworld
https://www.bioworld.com/articles/704703-other-news-to-note-for-jan-23-2024?v=preview
Other news to note for Jan. 23, 2024 | BioWorld
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Baird, BD, Bostongene, Dnanexus, Hamilton, Heartflow,...
news to notefor janbioworld
https://www.bioworld.com/articles/721689-new-prmt5-inhibitors-disclosed-in-apeiron-patent?v=preview
New PRMT5 inhibitors disclosed in Apeiron patent | BioWorld
Scientists at GT Apeiron Therapeutics and Shanghai Apeiron Biotechnology Co. Ltd. have divulged protein arginine N-methyltransferase 5 (PRMT5) inhibitors...
newinhibitorsdisclosedapeironpatent
https://www.bioworld.com/articles/691085-genfleet-therapeutics-patents-new-map4k1-inhibitors?v=preview
Genfleet Therapeutics patents new MAP4K1 inhibitors | BioWorld
Genfleet Therapeutics Inc. has divulged amine-substituted pyridine fused-ring compounds acting as mitogen-activated protein kinase kinase kinase kinase 1...
therapeuticspatentsnewinhibitorsbioworld
https://www.bioworld.com/articles/704907-discovery-of-novel-positive-allosteric-modulators-of-nampt?v=preview
Discovery of novel positive allosteric modulators of NAMPT | BioWorld
Novel nicotinamide phosphoribosyltransferase (NAMPT) positive allosteric modulators (N-PAMs) have been discovered and evaluated by University of Illinois and...
discovery ofnovelpositivemodulatorsnampt
https://www.bioworld.com/articles/659415-fda-approves-2-month-dosing-option-of-alkermes-aristada?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/topic/517-coronavirus?page=7
Coronavirus - Articles - Page 7 | BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
articles pagecoronavirusbioworld
https://www.bioworld.com/articles/661211-nd-l02-s0201-demonstrates-efficacy-in-preclinical-lung-fibrosis-models?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/653384-european-commission-approves-zavicefta-for-serious-bacterial-infections?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/topic/517-coronavirus?page=18
Coronavirus - Articles - Page 18 | BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
articles pagecoronavirusbioworld
https://www.bioworld.com/articles/topic/520-bioworld-science?page=3655
BioWorld Science - Articles - Page 3655
Daily news focused on drug discovery, delivery and preclinical research. Coverage includes: Congress highlights, key studies from peer-reviewed journals,...
bioworld sciencearticles page
https://www.bioworld.com/articles/648299-epirus-patents-nav1-7-channel-blockers?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/705274-shionogi-fronteo-developing-ai-diagnostic-support-models-for-dementia-depression?v=preview
Shionogi, Fronteo developing AI diagnostic support models for dementia, depression | BioWorld
ai diagnosticsupport modelsshionogideveloping
https://www.bioworld.com/articles/661088-chrysalis-presents-new-lysine-specific-demethylase-5b-inhibitors?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/674333-shanghai-meiyue-biotech-development-discovers-thrombin-and-factor-xia-inhibitors?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/728902-rx-10616-improves-radiotherapy-efficacy-in-hnscc?v=preview
RX-10616 improves radiotherapy efficacy in HNSCC | BioWorld
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by...
rximprovesradiotherapyefficacybioworld
https://www.bioworld.com/articles/643979-alkermes-reports-topline-results-from-phase-iii-study-of-alks-5461-for-major-depressive-disorder?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/648592-aduro-biotech-to-acquire-bionovion?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://bioworldpharma.com/index.php/product/etoricoxib-90-mg/
ETORINET-90 - Bioworld Pharma
Jun 9, 2023 - ETORICOXIB 90 MG Packing :- 10*10 ALU-ALU
bioworldpharma
https://www.bioworld.com/articles/648816-cell-culture-derived-influenza-vaccine-shows-excellent-immunogenicity?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/661789-niaid-presents-phase-ii-data-for-two-ebola-vaccines?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/661774-japan-tobacco-enters-licensing-agreement-for-rayaldee-in-japan?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://shop.illusivecomics.com/brands/bioworld/
BIOWORLD - Illusive Comics
bioworldillusivecomics
https://www.bioworld.com/articles/643468-discovery-of-a-novel-mab-able-to-inhibit-sporozoite-invasion-of-hepatocytes-in-vivo?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/685758-er-001259851-000-novel-selective-axl-inhibitor-with-promising-pk-profile-in-vivo?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/699712-bose-veterans-hear-the-sweet-cha-ching-of-sound-sleep-in-10m-series-a?v=preview
Bose veterans hear the sweet cha-ching of sound sleep in $10M series A | BioWorld
Three former employees of Bose Corp. are banking on their audio experience and Ozlo Sleepbuds helping the millions of people who struggle to sleep soundly each...
https://www.bioworld.com/authors/601-coia-dulsat
Coia Dulsat | BioWorld
BioWorld - Coia Dulsat
coiabioworld
https://www.bioworld.com/articles/730091-lilly-taps-insilico-ai-in-275b-deal-to-expand-pipeline-options?v=preview
Lilly taps Insilico AI in $2.75B deal to expand pipeline options | BioWorld
Eli Lilly and Co. is deepening its investment in artificial intelligence-driven drug discovery through a multibillion-dollar expansion of its collaboration...
https://www.bioworld.com/articles/topic/85-medical-technology?page=69
Medical technology - Articles - Page 69 | BioWorld
Daily news and analysis of the medical technology industry. In-depth coverage of business, financing, regulation, science, innovation, device approvals,...
medical technologyarticles pagebioworld
https://www.bioworld.com/articles/649034-autoimmune-disease-candidate-argx-113-enters-phase-i-trial-in-healthy-volunteers?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/703053-xinthera-patents-new-parp-1-inhibitors-for-cancer?v=preview
Xinthera patents new PARP-1 inhibitors for cancer | BioWorld
Xinthera Inc. has disclosed tricyclic poly(ADP-ribose) polymerase 1 (PARP-1; ARTD1) inhibitors reported to be useful for the treatment of cancer.
for cancerpatentsnewparpinhibitors
https://www.bioworld.com/articles/730099-janux-nominates-development-candidate-under-bms-collaboration?v=preview
Janux nominates development candidate under BMS collaboration | BioWorld
Janux Therapeutics Inc. has nominated a development candidate under its collaboration and exclusive worldwide license agreement with Bristol Myers Squibb Co....
developmentcandidatebmscollaborationbioworld
https://www.bioworld.com/articles/706199-akero-phase-iib-steatohepatitis-data-lift-shares-89bio-too
Akero phase IIb steatohepatitis data lift shares; 89bio, too | BioWorld
A preview of the next edition of BioWorld, March 4, 2024
akerophaseiibsteatohepatitisdata
https://www.bioworld.com/articles/679221-positive-preclinical-data-presented-for-multi-target-covid-19-vaccine?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/712535-riding-high-on-esmo-data-nuvalent-reaps-500m-in-offering
Riding high on ESMO data, Nuvalent reaps $500M in offering | BioWorld
A preview of the next edition of BioWorld, Sept. 17, 2024
riding highesmodata
https://www.bioworld.com/articles/681121-first-patient-dosed-in-pivotal-envasarc-study-of-envafolimab?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/725322-other-news-to-note-for-oct-21-2025?v=preview
Other news to note for Oct. 21, 2025 | BioWorld
Biopharma happenings, including deals and partnerships, and other news in brief: Contera, Cumberland Pharma, H. Lundbeck, Lava, Redhill, Xoma Royalty.
news to noteoctbioworld
https://www.bioworld.com/articles/720419-alx-oncology-presents-preclinical-data-plans-for-alx-2004?v=preview
ALX Oncology presents preclinical data, plans for ALX-2004 | BioWorld
ALX Oncology Holdings Inc. is set to begin phase I studies around the middle of this year with ALX-2004, an antibody-drug conjugate (ADC) for the treatment of...
preclinical dataalxoncologypresentsplans
https://www.bioworld.com/articles/707668-regulatory-actions-for-april-17-2024?v=preview
Regulatory actions for April 17, 2024 | BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Biorestorative...
regulatory actionsaprilbioworld
https://www.bioworld.com/articles/683137-new-antibiotic-prodrugs-synthesized-at-brandeis-university?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/topic/85-bioworld-medtech?page=10240
Medical technology - Articles - Page 10240 | BioWorld
Daily news and analysis of the medical technology industry. In-depth coverage of business, financing, regulation, science, innovation, device approvals,...
medical technologyarticles pagebioworld
https://www.bioworld.com/articles/topic/292-financings-bioworld-asia?page=384
Financings - Articles - Page 384 | BioWorld
Financing news, from idea to IPO
articles pagefinancingsbioworld
https://www.bioworld.com/articles/675122-results-form-phase-ii-study-of-galunisertib-in-mds?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/661296-dupilumab-given-fda-orphan-drug-status-for-eosinophilic-esophagitis?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/691057-other-news-to-note-for-nov-1-2022?v=preview
Other news to note for Nov. 1, 2022 | BioWorld
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biocytogen, Dragonfly, Eucure, Gilead, Isu, Ligand,...
news to notenovbioworld
https://www.bioworld.com/articles/730643-sun-pharma-to-acquire-merck-spinoff-organon-for-1175b?v=preview
Sun Pharma to acquire Merck spinoff Organon for $11.75B | BioWorld
sun pharmaacquiremerck
https://www.bioworld.com/articles/648217-nivolumab-gets-fda-orphan-drug-designation-for-the-treatment-of-hcc?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/702779-flagship-launches-new-offices-in-apac-uk-to-build-biotechs-overseas?v=preview
Flagship launches new offices in APAC, UK to build biotechs overseas | BioWorld
Serial biotech-founding venture fund Flagship Pioneering Inc., most noted for launching Moderna Inc. in 2012, is crossing into the Asia Pacific (APAC) region...
https://www.bioworld.com/articles/705021-biological-staging-system-proposed-for-parkinsons-disease?v=preview
Biological staging system proposed for Parkinson's disease | BioWorld
An international working group has proposed a new research framework that stages Parkinson's disease (PD) and defines it based on the disease's underlying...
staging systembiologicalproposedparkinsondisease
https://www.bioworld.com/articles/709170-other-news-to-note-for-june-5-2024?v=preview
Other news to note for June 5, 2024 | BioWorld
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aeterna, Alphamab, Alveolix, Arrivent, Astrazeneca,...
news to notejunebioworld
https://www.bioworld.com/articles/680464-azitra-discovers-recombinant-microorganisms-for-treating-atopic-dermatitis?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/691512-bioworld-medtech-patent-highlights-week-44?v=preview
BioWorld MedTech Patent Highlights: Week 44
BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.
bioworldmedtechpatenthighlightsweek
https://www.bioworld.com/articles/685402-researchers-identify-mtss1-as-a-novel-candidate-gene-for-inherited-retinal-dystrophy?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/661675-iterum-therapeutics-conducts-phase-i-study-of-sulopenem-etzadroxil?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/661548-first-in-human-study-shows-utility-of-11c-preladenant-in-imaging-brain-adenosine-receptors?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/648200-takeda-patents-ox1-receptor-antagonists?v=preview
| BioWorld
Breaking news and analysis of the global biotechnology, pharmaceutical, medical device and medical technology sectors. In-depth coverage of innovation,...
bioworld
https://www.bioworld.com/articles/699012-appointments-and-advancements-for-july-18-2023?v=preview
Appointments and advancements for July 18, 2023 | BioWorld
New hires and promotions in the med-tech industry, including: Eitan Medical, Lex Diagnostics, Medcura, Peca Labs, Tactile Medical.
appointmentsadvancementsjulybioworld
https://www.bioworld.com/articles/topic/85-medical-technology?page=1
Medical technology - Articles | BioWorld
Daily news and analysis of the medical technology industry. In-depth coverage of business, financing, regulation, science, innovation, device approvals,...
medical technologyarticlesbioworld